CORMIO, Gennaro
 Distribuzione geografica
Continente #
NA - Nord America 20.803
AS - Asia 7.704
EU - Europa 6.183
SA - Sud America 2.053
AF - Africa 218
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 36.993
Nazione #
US - Stati Uniti d'America 20.599
SG - Singapore 3.354
CN - Cina 1.958
BR - Brasile 1.823
IT - Italia 1.407
HK - Hong Kong 1.187
SE - Svezia 891
UA - Ucraina 842
DE - Germania 782
RU - Federazione Russa 759
FI - Finlandia 465
VN - Vietnam 441
GB - Regno Unito 362
FR - Francia 247
IN - India 141
CA - Canada 107
JP - Giappone 96
BD - Bangladesh 89
ID - Indonesia 77
AR - Argentina 76
IE - Irlanda 71
CI - Costa d'Avorio 63
IQ - Iraq 60
PL - Polonia 60
NL - Olanda 59
MX - Messico 56
BE - Belgio 55
ZA - Sudafrica 53
TR - Turchia 51
EC - Ecuador 45
AT - Austria 39
ES - Italia 37
LT - Lituania 33
VE - Venezuela 30
IR - Iran 29
KR - Corea 28
PK - Pakistan 27
MA - Marocco 24
KE - Kenya 23
SA - Arabia Saudita 21
CL - Cile 19
UZ - Uzbekistan 19
CO - Colombia 18
AE - Emirati Arabi Uniti 15
PY - Paraguay 15
AU - Australia 13
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
EG - Egitto 11
PE - Perù 11
CH - Svizzera 10
EU - Europa 10
UY - Uruguay 10
HN - Honduras 9
OM - Oman 9
TT - Trinidad e Tobago 9
JO - Giordania 8
SN - Senegal 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
IL - Israele 7
KZ - Kazakistan 7
MY - Malesia 7
NP - Nepal 7
AL - Albania 6
EE - Estonia 6
LB - Libano 6
RO - Romania 6
LK - Sri Lanka 5
AO - Angola 4
BG - Bulgaria 4
BH - Bahrain 4
CR - Costa Rica 4
JM - Giamaica 4
KG - Kirghizistan 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
LU - Lussemburgo 3
MM - Myanmar 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PS - Palestinian Territory 3
BN - Brunei Darussalam 2
GH - Ghana 2
GR - Grecia 2
KH - Cambogia 2
NC - Nuova Caledonia 2
PA - Panama 2
QA - Qatar 2
Totale 36.957
Città #
Fairfield 2.254
Ashburn 1.793
Woodbridge 1.765
Jacksonville 1.717
Chandler 1.662
Singapore 1.640
Hong Kong 1.181
Houston 1.105
Cambridge 946
Seattle 921
Ann Arbor 762
Wilmington 747
Dallas 684
Nyköping 664
Beijing 576
Lawrence 416
Roxbury 413
Nanjing 349
New York 273
Des Moines 254
Boardman 243
Los Angeles 241
Bari 211
Princeton 187
Dearborn 185
São Paulo 157
Ho Chi Minh City 127
Inglewood 125
Munich 105
San Diego 105
Shenyang 102
Buffalo 101
Nanchang 99
Santa Clara 97
Tokyo 91
Hebei 88
Hanoi 86
Dong Ket 85
Jiaxing 81
Milan 74
Brooklyn 73
Helsinki 72
London 71
Rio de Janeiro 66
Abidjan 63
Rome 62
Dublin 60
Paris 57
Moscow 55
Brussels 54
Chicago 53
Jakarta 50
Tianjin 47
Changsha 46
Redwood City 45
Brasília 44
San Francisco 44
Warsaw 43
Guangzhou 40
Washington 39
Toronto 38
Belo Horizonte 32
Hefei 32
Montreal 31
Nuremberg 31
Chennai 30
Johannesburg 29
Curitiba 28
Matera 27
Phoenix 27
Auburn Hills 26
Dhaka 26
Frankfurt am Main 25
Leawood 25
Pune 25
Turku 23
Charlotte 22
Shanghai 22
Stockholm 22
Jinan 21
Nairobi 21
San Mateo 21
Salvador 20
Denver 19
Kunming 19
Manchester 19
The Dalles 19
Amsterdam 18
Ankara 18
Augusta 18
Norwalk 18
Palermo 18
Ardabil 17
Baghdad 17
Boston 17
Campinas 17
Guayaquil 17
San Jose 17
Catania 16
Council Bluffs 16
Totale 24.700
Nome #
Assottigliamento dell'anello stromale cervicale alal risonanza magnetica nucleare in pazienti con cervicocarcinoma stadio Ib-IIa: un possibile elemento predittivo di invasione extracervicale 663
Tumore desmoide del muscolo retto addominale, simulante una massa pelvica 310
The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication 185
Preoperative sonographic assessment of a leiomyoma of the round ligament 184
A case of sarcoidosis mimicking recurrences of endometrial cancer. 184
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) 183
A phase II study: dose-dense carboplatin and paclitaxel as neoadjuvant chemotherapy in locally advanced cervical cancer 177
Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. 170
Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report 168
Un caso di gravidanza gemellare con coesistenza di un feto normale e una mola vescicolare 165
Goblet-cell carcinoid of the ovary: A case report with ultrastructural analysis 164
1.Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. 159
Blue mass in pelvis: serous cystadenofibroma of peritoneum 157
Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling 156
Sonographic and Power Doppler Evaluation of an Invasive Mole Located in a Cesarean Scar Pregnancy. 154
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 153
116.Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients. 150
Endometrioma of the Abdominal Wall after Caesarean Section 148
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 147
A rare case of choroidal metastasis presented after conservative management of endometrial cancer 146
Increase in proteins involved in mitochondrial fission, mitophagy, proteolysis and antioxidant response in type I endometrial cancer as an adaptive response to respiratory complex I deficiency 145
Rapid growth of myxoid leiomyosarcoma of the vulva during pregnancy: a case report 143
84.Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix 140
Diagnostic accuracy of hysteroscopy in endometrial hyperplasia. 138
Ddx4+ Oogonial Stem Cells in Postmenopausal Women's Ovaries: A Controversial, Undefined Role 137
Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. 132
83.Brachytherapy for isolated vaginal recurrences from endometrial carcinoma. 131
A very unique case of heterotopic pregnancy 131
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24) 130
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 130
Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases 129
Regulation of the expression of CLU isoforms in endometrial proliferative diseases. 129
Breast cancer: an update on treatment-related infertility 129
BONE METASTASES AS PRESENTING SIGN OF MAMMARY-LIKE VULVAR ADENOCARCINOMA 128
Lipoperoxidation and antioxidant enzymes activity in pregnancy complicated with hypertension 127
A case of sarcoidosis mimicking recurrences of endometrial cancer. 126
87.Pure lipoma of the uterus in association with endometrial carcinoma. 123
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 123
A RISK MODEL FOR SECONDARY CYTOREDUCTIVE SURGERY IN RECURRENT OVARIAN CANCER: AN EVIDENCE-BASED PROPOSAL FOR PATIENT SELECTION 122
Pregnancy related cancer in Apulia. A population based linkage study. 121
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma 119
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 119
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 119
Pseudo-Meigs syndrome and elevated Ca125 associated with struma ovarii 118
Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 118
Transvaginal color Doppler sonography in predicting the response to chemotherapy in advanced cervical cancer 117
3D ultrasound diagnosis of molar caesarean scar pregnancy. 117
120.[Nuclear Magnetic Resonance Imaging in the staging of adenocarcinoma of the uterine cervix]. 116
Carcinosarcoma of the vulva: a case report 116
Prognostic Factors and Outcomes in 28 Cases of Uterine Leiomyosarcoma 116
Antimicrobial prophylaxis in laparoscopic gynecologic surgery: a prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin 115
Mucinous tumor of uncertain malignant potential of the appendix mimicking ovarian cancer: a case report. 114
Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression 114
Title ultrasound features of ovarian melanoma metastases : the "golf Ball" aspect 114
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 114
Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel 113
BRCA1/2 MUTATIONS AND ‘’FOUNDER EFFECT’’ : THE CASE OF APULIA 113
CHOLANGIOCARCINOMA IN PREGNANCY: TWO LIVES AT RISK. AN UNRESOLVED ISSUE 113
L'accesso al retroperitoneo nella linfadenectomia lombo-aortica per carcinoma ovarico 112
Do We Need Antibiotic Prophylaxis In Operative Hysteroscopy? 112
Carcinoma squamoso primitivo della vagina su cistocele da prolasso vaginale post-isterectomia 112
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): The MITO-9 study 111
MtDNA content in the progression of endometrial pathology from normal endometrium to hyperplasia to type I endometrial carcinoma 110
MALIGNANT MIXED MÜLLERIAN TUMOUR (MMMT) OF THE UTERUS: ANALYSIS OF 44 CASES 110
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer 110
A machine learning tool to predict the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer 110
A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer 109
Mitochondrial changes in endometrial carcinoma: Possible role in tumor diagnosis and prognosis (Review) 109
Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9). 109
Uterine tumour resembling an ovarian sex-cord tumour presenting with spontaneous haemoperitoneum in pregnancy 109
Brain metastases from a primary carcinoma of the fallopian tube. 108
Intramedullary spinal cord metastasis from ovarian carcinoma 108
[Acute urinary retention in uterine myoma: description of a case]. FT Ritenzione urinaria acuta da mioma uterino: descrizione di un caso 108
DOSE-DENSE WEEKLY CARBOPLATIN AND PACLITAXEL AS NEOADJUVANT CHEMOTERAPY IN LOCALLY ADVANCED CERVICAL CANCER 108
Central nervous system metastases from epithelial ovarian cancer: prognostic factors and outcomes. 108
The PGC-1a-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. 106
A case of acute lymphoblastic leukaemia mimicking an ovarian malignant tumor 106
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study 105
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience 104
Massive groin node metastasis as presenting sign of squamous cell carcinoma of the fallopian tube 104
Borderline epithelial tumors of the ovary: experience of 55 patients 104
Antimicrobial prophylaxis in vaginal gynecologic surgery: a prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin 103
Prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin as antimicrobial prophylaxis in laparotomic gynecologic surgery. 103
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study 103
Prenatal diagnosis of twin pregnancies with complete Hydatiform mole and coexistent normal fetus: a series of 13 cases. 103
Bowel Dysfunction following Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Prospective Study. 103
Central nervous system involvement from epithelial ovarian cancer 102
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study 102
Prolonged survival of stage IV malignant mixed Müllerian tumor of the ovary after carboplatin, mesna, ifosfamide, and cis-platin chemotherapy: case report 102
US and MR Findings in Primary Vaginal Leiomyoma: A Case Report. 102
GROIN RECURRENCE IN CARCINOMA OF THE VULVA: MANAGEMENT AND OUTCOME 102
Locally-advanced cervical cancer associated with complete uterine prolapse 102
Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma 102
Ultra-short term prophylaxis with ceftazidime is effective in gynecologic oncology surgery 101
Surgical decompression and radiation therapy in epidural metastasis from cervical cancer 101
Ultrasound presurgical staging in endometrial cancer. 101
Paget disease of the vulva an analysis of 24 cases 101
Chemotherapy in Recurrent Vulvar Carcinoma: A Phase II Study Using Combination of Cisplatin and Vinorelbine 100
Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study 100
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 100
Totale 13.047
Categoria #
all - tutte 166.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.369 0 0 0 0 0 288 420 208 388 514 303 248
2021/20222.749 175 370 35 187 89 146 114 191 133 156 425 728
2022/20234.534 674 349 215 433 633 601 52 506 824 30 121 96
2023/20241.725 136 356 104 148 174 371 63 96 20 42 38 177
2024/20256.699 139 82 587 252 183 579 496 570 252 361 963 2.235
2025/20267.010 2.063 1.033 817 1.436 1.452 209 0 0 0 0 0 0
Totale 37.668